Alcohol

Unsafe

Avoid consumption of alcohol while taking Abacavex 300 mg Tablet 30's as it may have the risk of developing Osteonecrosis (a condition in which parts of the bone tissue die because of reduced blood supply to the bone).

Pregnancy

Caution

Abacavex 300 mg Tablet 30's is generally not recommended for use in pregnancy. If you are pregnant, inform your doctor before taking Abacavex 300 mg Tablet 30's. There are limited data available on the effect of this medicine in pregnancy. Animal studies have shown carcinogenic effects.

Breast Feeding

Unsafe

Avoid breastfeeding while taking Abacavex 300 mg Tablet 30's. HIV-positive women must not breastfeed as HIV infection can be passed to the baby in breast milk.

Driving

Caution

Do not drive or operate machines if you are not alert after taking this medicine.

Liver

Caution

Abacavex 300 mg Tablet 30's is primarily metabolised by the liver. No dose adjustments are necessary for patients with moderate liver impairment. If this medicine is taken in moderate liver conditions, close monitoring of liver functioning is needed. In individuals with moderate or severe hepatic impairment, abacavir should not be used unless absolutely necessary as no clinical data are available.

Kidney

Caution

If you have kidney disease, inform your doctor before taking Abacavex 300 mg Tablet 30's. Your doctor may adjust the dose if necessary based on your condition. This medicine is not recommended if you have severe kidney disease.

Children

Caution

The safety and effectiveness of Abacavex 300 mg Tablet 30's in children below three months have not been established. For children above three months, the dose, dosage form and duration will be determined by the doctor based on the child’s body weight.